CAR T-cell Therapy: Understanding the Warning and the Risks
The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
Emerging Treatments for Brain Metastases in Breast Cancer
SABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
by Marci A. Landsmann
From the Editor-in-ChiefCancer Treatment: Can Less Be More?
Molecular profiling that has led to spectacular advances in cancer treatment may also improve cancer survivorship.
by William G. Nelson, MD, PhD
Forward LookCDK4/6 Inhibitors in Early-stage Breast Cancer
A mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.
by Darcy Lewis
Forward LookIs Immunotherapy Safe in People With HIV?
Study supports the use of immune checkpoint inhibitors in an understudied population.
by Carolyn Bernhardt
Controlling Peripheral Neuropathy
Researchers are looking at ways to lessen and even prevent the debilitating chemotherapy-related side effect that causes numbness and pain in the hands and feet.
by Cameron Walker
Moving the Needle on Metastatic Breast Cancer
Metastatic breast cancer remains incurable, but researchers’ understanding of the molecular features of the disease is leading to additional treatments.
by Erin O’Donnell
Finding Answers in Prostate Cancer
PSMA PET imaging is helping clinicians more accurately stage prostate cancer and provide precision treatment.
by Sandra Gordon
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
Germline Genetic Testing Lags Behind Guidelines
Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey